2. Schechter MT, Ballem PJ, Buskard NA, et al: An anonymous seroprevalence survey of HIV infection among pregnant women in British Columbia and the Yukon Territory. Can Med Assoc J 1990; 143: 1187-1192

3. Hankins CA, Laberge C, Lapointe N, et al: HIV infection among Quebec women giving birth to live infants. Can Med Assoc J 1990; 143: 885-893

4. Coates RA, Frank JW, Arshinoff R, et al: The Ontario HIV seroprevalence study of childbearing women: results from the first year of testing. Clin Invest Med 1992; 15: 1-7

5. Peckham CS, Tedder RS, Briggs M, et al: Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet 1990; 335: 516-519

6. Lifson AR, Chiasson MA, Stoneburner RL: Screening for HIV infection in sexually transmitted disease clinics. N Engl J Med 1988; 319: 242-243

7. Landesman S, Minkoff H, Holman S, et al: Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women. JAMA 1987; 258: 2701-2703

8. Barbacci MB, Dalabetta GA, Repke JT, et al: Human immunodeficiency virus infection in women attending an inner-city prenatal clinic: ineffectiveness of targeted screening. Sex Transm Dis 1990; 17: 122-126

9. Fehrs LJ, Hill D, Kerndt PR, et al: Targeted HIV screening at a Los Angeles prenatal/family planning health center. Am J Public Health 1991; 81: 619-622

10. Lindsay MK, Feng TI, Peterson HB, et al: Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients. Obstet Gynecol 1991; 77: 599-603

11. Wenstrom KD, Zuidema LJ: Determination of the seroprevalence of human immunodeficiency virus infection in gravidas by non-anonymous versus anonymous testing. Obstet Gynecol 1989; 74: 558-561

12. Human immunodeficiency virus infection in the United States: a review of current knowledge. MMWR 1987; 36: 1-48

13. Pizzo PA: Pediatric AIDS: problems within problems. J Infect Dis 1990; 161: 316-325

14. Husson RN, Comeau AM, Hoff R: Diagnosis of human immunodeficiency virus infection in infants and children. Pediatrics 1990; 86: 1-10

15. Walter EB, McKinney RE, Lane BA, et al: Interpretation of western blots of specimens from children infected with human immunodeficiency virus type 1: implications for prognosis and diagnosis. J Pediatr 1990; 117 (2 Pt 1): 255-258

16. McCusker J, Stoddard AM, Mayer KH, et al: Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men. Am J Public Health 1988; 78: 462-467

17. Schechter MT, Craib KJP, Willoughby B, et al: Patterns of sexual behavior and condom use in a cohort of homosexual men. Am J Public Health 1988; 78: 1535-1538

18. Van Griensven GJP, de Vroome EMM, Tielman RAP, et al: Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men. Am J Epidemiol 1989; 129: 596-603

19. Van Griensven GJP, De Vroome EMM, Tielman RAP, et al: Impact of HIV antibody testing on changes in sexual behavior among homosexual men in the Netherlands. Am J Public Health 1988; 78: 1575-1561

20. Robertson JR, Skidmore CA, Roberts JJK: HIV infection in intravenous drug users: a follow-up study indicating changes in risk-taking behaviour. Br J Addict 1988; 83: 387-391

21. Volberding PA, Lagakos SW, Koch MA, et al: Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer then 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322: 941-949

22. Pedersen C, Sandstrom E, Petersen CS, et al: The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. N Engl J Med 1990; 322(25): 1757-1763

23. Leibovitz E, Rigaud M, Pollack H, et al: Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes per cubic millimeter. N Engl J Med 1990; 323(8): 531-533

24. Hamilton JD, Hartigan PM, Simberkoff MS, et al: A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs cooperative study. N Engl J Med 1992; 326: 437-443

25. Hirschel B, Lazzarin A, Chopard P, et al: A controlled study of inhaled pentamidine for primary prevention of Pneumocystis Carinii pneumonia. N Engl J Med 1991; 324: 1079-1083

26. Fox R, Odaka NJ, Brookmeyer R, et al: Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS 1987; 1: 241-246

27. Frazer IH, McCamish M, Hay I, et al: Influence of human immunodeficiency virus antibody testing on sexual behaviour in a "high-risk" population from a "low-risk" city. Med J Aust 1988; 149: 365-368

28. van Griensven GJP, de Vroome EMM, Goudsmit JAAP, et al: Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. BMJ 1989; 298: 218-221

29. Kim HC, Raska K, Clemow L: Human immunodeficiency virus infection in sexually active wives of infected hemophilic men. Am J Med 1988; 85: 472-476

30. Laurian Y, Peynet J, Verroust F: HIV infection in sexual partners of HIV-seropositive patients with hemophilia. N Engl J Med 1989; 320: 183

31. Casadonte PP, Des Jarlais DC, Friedman SR, et al: Psychological and behavioral impact among intravenous drug users of learning HIV test results. Int J Addict 1990; 25(4): 409-426

32. Martin GS, Serpelloni G, Galvan U, et al: Behavioural change in injecting drug users: evaluation of an HIV/AIDS education programme. AIDS Care 1990; 2: 275-279

33. McKeganey N: Being positive: drug injectors' experiences of HIV injection. Br J Addict 1990; 85: 1113-1124

34. Centers for Disease Control: Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR-Morb-Mortal-Wkly Rep 1989; 38(Suppl 5): 1-9

35. Centers for Disease Control: Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 1991; 40(RR-2): 1-13

36. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services: as Assessment of the Effectiveness of 169 Interventions. Williams & Wilkins, Baltimore, Md, 1989: 139-146, 331-339

37. Canadian Task Force on the Periodic Health Examination: The periodic health examination, 1992 update: 3. HIV antibody screening. Can Med Assoc J 1992; 147: 867-876